Djokovic acquired part of a company that researches treatments against Covid-19

Tennis player Novak Djokovic, number 1 in the ATP world rankings, has 80% of the Danish biotechnology company QuantBioRes, which seeks to develop a medical treatment against COVID-19, the company’s director revealed today. He is one of the founders of my company, created in June 2020,” Ivan Loncarevic, the company’s director, told French news agency AFP. The company is developing a peptide that inhibits coronavirus infection in the human cell and expects to start clinical trials in Britain this summer. Our goal is to develop a new technology to combat resistant viruses and bacteria and we have decided to use Covid as a showcase. If we get it with Covid-19, we will achieve it with all the other viruses,” said Loncarevic.It is worth mentioning that the world number one was deported from Australia last Sunday and could not play the Grand Slam that is played in that country, because they canceled his visa for not being vaccinated against the coronavirus. With his forced departure from Australian territory, the Serbian loses a new chance to become the tennis player with the most major tournaments won in the history of men’s tennis, since so far he has 20 titles, the same amount as the Spanish Rafael Nadal and the Swiss Roger Federer. 

Original source in Spanish